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Key Clinical Message
An implantable cardioverter defibrillator (ICD) lead dislodgement into the right
atrium is a dangerous situation, particularly in patients in atrial fibrillation
because atrial fibrillation can be sensed as ventricular fibrillation and true ven-
tricular fibrillation induced with an inappropriate shock. In the presence of
shocks, ICD interrogation should be performed as soon as possible.
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Introduction
The implantable cardioverter defibrillator (ICD) is the
standard of care for secondary prevention in patients with
previous cardiac arrest and for primary prevention in
appropriately selected patients with structural heart disease
[1–3]. Despite the benefit in terms of survival, the ICD is
cause of important morbidity and decrease in quality of
life in some patients. Device infection, lead dislodgement,
recalls from the industry needing reoperation, and inap-
propriate therapies are some of the adverse events follow-
ing ICD implantation [4]. In this manuscript, we describe
the case of a patient that received six inappropriate ICD
shocks that seriously threatened her life.
Case Report
A 65-year-old female patient with a history of prosthetic
mechanical mitral valve replacement due to rheumatic
heart disease and long-standing persistent atrial fibrilla-
tion (AF) was implanted with a single-chamber ICD as a
secondary prevention, 1 month after a fully recovered car-
diac arrest due to ventricular fibrillation (VF). A coronary
angiography ruled out severe coronary disease. An
echocardiogram documented preserved left ventricular
ejection fraction with a mild to moderate prosthetic leak,
moderate tricuspid regurgitation, and severe left atrium
enlargement. An active fixation lead was used and posi-
tioned in the septo-apical right ventricular area. The
intra- and postoperative lead parameters were within nor-
mal ranges. The ICD was programmed as follows: one
zone—VF zone—with detection at 200 bpm and therapy
with six shocks (the first one set to 15J and the following
five set to maximum-energy-36J). The intra-operative lead
position was confirmed by a chest X-ray predischarge.
Testing of ventricular lead 1 week after the implant was
also within normal range for threshold, impedance, and
R-wave sensing.
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The patient was admitted to the emergency department
3 months later after receiving six consecutive shocks. She
denied any cardiac symptoms before the event. The
patient referred suffered sudden loss of consciousness
immediately after the first shock. A direct witness
described that she remained unconscious until at least
two more shocks were delivered. Thereafter, three more
shocks followed while the patient was fully conscious.
The stored intracardiac electrograms (EGMs) of the
event are shown in Figures 1 and 2. The analysis of the
episode revealed a sudden change to rapid and irregular
sensed activity in the bipolar ventricular channel, that
(A)
(B)
(C)
Figure 1. EGMs of the episode are shown in consecutive strips. The upper channel shows the far-field, the middle one corresponds to the near-
field (ventricular tip- ventricular ring), and the lower one to the markers. Panel A: A sudden shortening in basal cycle length that reach VF zone is
shown in the near-field channel, while the far-field channel remains in the patient´s basal rhythm. Panel B: VF detection criteria are met, and an
unsynchronized shock is delivered inducing VF (change in far-field channel). Panel C: VF is registered in the far-field channel, while AF is
undersensed in the near-field and a subsequent shock is canceled. Activador = VF therapy activated and start of charging, EGMs = intracardiac
electrograms, F = ventricular fibrillation detection, FV = VF detection criteria met, Regreso a sinusal = sinus rhythm restored, VF = ventricular
fibrillation, VS = ventricular sensing.
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Figure 2. EGMs of the episode are shown in consecutive strips. The upper channel shows the far-field, the middle one corresponds to the near-
field (ventricular tip- ventricular ring), and the lower one to the markers. Panel A: VF is shown in far-field channel, while unstable low signals are
registered in the near-field channel. Panel B: A stable period of VF detection that fulfilled diagnosis criteria led to a shock that limits VF (see far-
field channel). Panels C and D: Redetection of AF in the near-field channel within the VF zone induces a shock that restores sinus rhythm.
Activador = VF therapy activated and start of charging, EGMs = intracardiac electrograms, F = ventricular fibrillation detection, FV = VF
detection criteria met, VF = ventricular fibrillation VP = ventricular pacing, VS = ventricular sensing, Regreso a sinusal = sinus rhythm restored.
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reached VF zone. At the same time, the far-field channel
showed persistence of patient0s basal rhythm (AF with
controlled ventricular response) (Fig. 1). This could only
be explained by cross talk sensing of atrial signal during AF
in the bipolar ventricular lead, probably due to lead dis-
lodgement. An unsynchronized shock was delivered, and
VF was induced. This was documented by the far-field
channel (Fig. 1), which explains the sudden loss of con-
sciousness immediately after the discharge. Then, during a
20-sec period, the rapid and irregular atrial activity was
alternatively sensed and undersensed by the ventricular lead
due to low signals, coexisting with VF that was still regis-
tered by the far-field channel (Fig. 1). Undersensing of low
signals in the ventricular lead led to delay a subsequent
shock. Providentially, it was followed by a stable AF sensing
period in the ventricular lead that led, initially to a second
ineffective shock (not shown), and subsequently to a third
inappropriate but life-saving shock, that defibrillated VF
(Fig. 2). Finally, the device still detecting rapid atrial elec-
trical activity delivered a fourth shock that restored sinus
rhythm (Fig. 2). Posteriorly, AF recurred and the device
delivered two more inappropriate shocks (not shown) that
effectively restored sinus rhythm. The patient was admitted
and a chest X-ray confirmed dislodgement of the ventricu-
lar lead in the right atrium (Fig. 3).
A second intervention was scheduled and consequently
performed. The ventricular lead was positioned into the
right ventricular apex and firmly fixed to ensure its stabil-
ity. During the follow-up, the patient remained unevent-
ful without neurological sequelae.
Discussion
The most common causes of inappropriate ICD therapies
are supraventricular tachycardia, especially AF or atrial
flutter with rapid ventricular response, T-wave oversens-
ing, and lead dysfunction (noise and myopotentials) [5].
Inappropriate therapies are associated with an adverse
effect on health outcomes, quality of life, and mortality
[6–8], but direct fatal proarrhythmia has been occasion-
ally published [9–11].
In this case, lead dislodgment into the right atrium
with AF led to inappropriate unsynchronized shock that
induced VF. This mechanism has been previously
reported as a fatal mechanism of inappropriate therapy
[9]. Low AF signals could be undersensed and start anti
bradycardia pacing while VF. However, in this case, inter-
mittent sensing of atrial signal during AF led to a subse-
quent shock that terminated VF and a following discharge
restored sinus rhythm and limited inappropriate thera-
pies. To our knowledge, this represents the first case doc-
umenting both life-threatening and life-saving
inappropriate therapies secondary to AF oversensing.
Our report underlines the importance of an ICD inter-
rogation as soon as possible after a shock. In a setting of
a dislodged lead, the patient should be continuously mon-
itored and the ICD should be immediately inactivated
until the lead is repositioned.
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